Final Results
Victrex PLC
06 December 2005
6th December 2005
Victrex plc
Results announcement for the year ended 30th September 2005
O Turnover up 17% to £101.6m (2004: £86.6m)
O Gross margin up 2% points to 57.1% (2004: 55.1%)
O Profit before taxation up 23% to £35.1m (2004: £28.5m)
O Final dividend of 9.3p making a total of 12.0p for the year, an
increase of 40%
Chairman Peter Warry commented:
'Victrex has continued to make excellent progress this year with record sales
and profits, further organic growth, continued success in developing new product
applications and markets, and consolidation of our supply chain.
Sales volume has shown some strengthening since the year end. If this level of
demand is sustained, first half volume will be higher than the second half of
last year.
Despite weakening in our effective exchange rates, we still expect further
enhancement in our gross margin for the year to 30 September 2006, principally
due to the benefits arising from the recent acquisition of the BDF operations.'
Enquiries
Victrex plc
David Hummel, Chief Executive 0207 357 9477 (6th December 2005)
Michael Peacock, Finance Director 01253 897700 (thereafter)
Hogarth Partnership Limited
Nick Denton / Barnaby Fry 0207 357 9477
Victrex plc
Preliminary results statement for the year ended 30th September 2005
Victrex has continued to make excellent progress this year with record sales and
profits, further organic growth, continued success in developing new product
applications and markets, and consolidation of our supply chain.
RESULTS
Turnover for the year was £101.6m (2004: £86.6m). Gross profit increased by
21.7% to £58.0m (2004: £47.7m), representing 57.1% of turnover (2004: 55.1%).
Sales, marketing and administrative expenses increased by 19.2% to £23.7m (2004:
£19.9m), primarily as a result of our ongoing investment programme in product
development and marketing, together with increased staff bonuses.
Profit before tax was £35.1m (2004: £28.5m) up 23.3% and basic earnings per
share were up 22.6% at 29.3p (2004: 23.9p). Compared with the previous year,
exchange rates have had an adverse impact of £2.2m on profit, principally due to
a weaker Dollar offset by a marginally stronger Euro.
The overall effective tax rate (including deferred tax) remained at 32.5%.
CASH FLOW
Cash flow from operating activities increased to £37.2m (2004: £32.3m) primarily
as a result of improved trading.
The purchase on 1 April 2005 of the raw material manufacturing operations from
Degussa resulted in a cash payment of £17.7m (including associated acquisition
costs). Other capital expenditure for the year totalled to £6.0m (2004: £9.5m)
and was mainly related to the design of our second powder plant, the extension
of our UK technology centre and further investment in existing infrastructure.
Taxation paid was £9.7m (2004: £6.1m) as a result of increased profits.
At the year end, the Group had net cash of £15.8m (2004: £17.0m). The Group has
a committed bank facility of £40m, all of which was undrawn at the year end.
This facility expires in September 2008.
DIVIDEND
In recognition of the continuing strong performance of the Company and the clear
path forward on our capital expenditure programme, the Directors are
recommending a rebasing of the final dividend to 9.3p (2004: 6.2p) per ordinary
share, making a total of 12.0p (2004: 8.6p) per ordinary share for the year, an
increase of 40% over last year. This represents dividend cover of 2.4 times.
INTERNATIONAL FINANCIAL REPORTING
These results are the last to be published under UK Generally Accepted
Accounting Practice ('UK GAAP'). The Group has adopted International Financial
Reporting Standards ('IFRS') with effect from 1 October 2005. Accordingly, the
Group's interim results and financial statements for the year to 30 September
2006 will be prepared in compliance with IFRS. In order to provide an indication
of the main effects of IFRS implementation on the Group's results, an unaudited
restated income statement for the year ended 30 September 2005, balance sheets
as at 30 September 2004 and 2005 together with reconciliations from UK GAAP to
IFRS are set out in a separate announcement made today.
The impact on the results for the year ended 30 September 2005 is summarised
below:
UK GAAP IFRS Variance
Profit before taxation £35.1m £35.3m £0.2m
Earnings per share 29.3p 29.9p 0.6p
Closing equity shareholders' funds £90.2m £92.2m £2.0m
MARKETS
Total sales volume increased by 9.4% to 1,972 tonnes (2004: 1,802 tonnes) with
second half volume of 984 tonnes (2004: 933 tonnes) compared with 988 tonnes
(2004: 869 tonnes) for the first half.
Of our three principal market segments, industrial sales volume was up 22.7% on
2004 at 626 tonnes, largely due to increasing demand from oil and gas and
chemical processing customers. Second half sales of 337 tonnes were up 16.6% on
the first half of 289 tonnes.
Transport sales volume was 552 tonnes, an increase of 9.7% over the previous
year, as a result of increased automotive sales in Europe and Asia-Pacific and
an upturn in commercial aerospace volume in the United States. The second half
saw a slight softening in automotive sales and, as a result, volume was 265
tonnes, 7.7% down on the first half (287 tonnes).
Electronics sales volume for the year was down 3.6% on 2004 at 557 tonnes as a
result of a 15.7% reduction in semiconductor sales, which was partially offset
by a 16.9% increase in sales volume for consumer electronics applications.
Second half sales volume of 265 tonnes was 9.2% below the first half of 292
tonnes. This was due to consumer electronics volume running below record first
half levels offset by some recovery in semiconductor sales.
Regionally, we achieved another year of significant growth in Asia-Pacific where
volume increased to 395 tonnes, up 35.7% on last year's record levels. This was
largely due to the continued penetration of new consumer electronics
applications in the first half combined with a recovery in semiconductor sales
in the second half. Second half sales volume (185 tonnes) was 12% lower than the
record first half (210 tonnes) due to lower Japanese sales.
Europe also achieved record sales volume which, at 969 tonnes for the year, was
7.0% up on 2004. Growth came mainly from the automotive and industrial segments.
Second half volume (472 tonnes) was 5% down on the strong first half performance
(497 tonnes).
At 608 tonnes, United States volume was in line with the previous year. There
was a strong recovery in the second half with sales volume of 327 tonnes, up
16.4% on the first half (281 tonnes) due to increased demand in the oil and gas
and chemical processing segments.
BUSINESS DEVELOPMENT
Victrex continues to invest in new products and platforms to extend the market
range of products derived from our core polyketone technology. In 2005, we
further expanded our grade range and successfully realised initial sales of new
platforms such as VICTREX High Flow PEEK (into thin-walled automotive
applications) and VICTREX Ultra-High Purity PEEK (into the semiconductor
market).
In addition, we significantly expanded both our application pipeline and sales
into the coating and film areas which we believe offer major new market
opportunities for Victrex. In coating products, we commercialised new VICTREX
PEEK coating applications for industrial and consumer components, leveraging
VICTREX PEEK's unique combination of excellent wear and outstanding abrasion
resistance. In film, we are developing a broad range of new applications,
including speaker components, wire insulation, and substrates in consumer
electronic components.
Our focus on major markets continues, as we define the next generation of
applications where VICTREX PEEK not only improves performance but, in many
cases, can reduce total system costs. In transport, we continue to focus on
electro-mechanical components which demand superior performance in applications
such as emergency brakes and ABS systems; while driving new opportunities such
as electronic exhaust sensor systems to ensure emission standards are met. In
oil and gas, VICTREX PEEK is enabling oil companies and their suppliers to
develop downhole systems to access oil reserves where extreme temperature and
chemical environments preclude the use of most other polymers. We support these
evolving industry needs with both materials and applications knowhow, assisting
the end user in developing complete systems solutions to accelerate the adoption
of VICTREX PEEK.
The continuing effectiveness of our development programmes is best demonstrated
by our ongoing success in delivering new applications. During the year we
commercialised 475 new applications (2004: 436) having an estimated mature
annualised volume ('MAV') of 351 tonnes (2004: 305 tonnes). At the year end, the
pipeline contained 1,433 developments (2004: 1,431) with an estimated MAV of
2,344 tonnes (2004: 2,051 tonnes) if all of the developments were successfully
commercialised.
As part of our continual effort to better meet customers' needs and drive
further growth in Asia, we are investing in a new Asian Innovation and
Technology Centre which will be located in Shanghai, China. The Centre,
scheduled to open in Summer 2006, will provide customers with expertise in
material specification, testing, research and application development.
INVIBIO(R)
Invibio has enjoyed another excellent year with turnover of £11.1m, showing an
increase of 97.2% over 2004 (£5.7m). This reflects continued core product sales
growth and successful development of new business across a broad range of end
use markets.
During the year we entered into 33 additional PEEK-OPTIMA(R) polymer long-term
supply assurance agreements with implantable medical device manufacturers.
Important developments were realised in strategic market areas including
arthroscopy, dental, orthopaedic, trauma and neurostimulation.
Initial sales of PEEK-CLASSIX(R) polymer (launched last year), designed and
manufactured for short term blood and tissue contact, have been ahead of
expectations. Invibio also recently launched ENDOLIGN(TM) polymer, a continuous
carbon fibre reinforced product, for use in orthopaedic applications where
strengths comparable to implantable metals are required.
Historically, Invibio's business has been focused on the US and European
markets. We are now expanding into Asia-Pacific and are opening our first Asian
office in Hong Kong. Long-term implantable devices that utilise PEEK-OPTIMA
polymer have already been approved in China, Taiwan and, most recently, Japan.
SUPPLY CHAIN
The acquisition of the operations of Degussa AG relating to the manufacture of
BDF (the key raw material from which VICTREX PEEK is produced) during the year
has consolidated Victrex's control of the BDF supply chain following our
previous acquisition of the primary manufacturing stage in 1999.
The newly acquired operations principally comprise an oxidation plant which
undertakes the secondary manufacturing stage of BDF and a plant that
manufactures fluoroboric acid (a key raw material for the primary manufacturing
stage).
The supply chain can currently support 2,800 tonnes per annum of VICTREX PEEK
sales. To allow us to meet our growth expectations and demonstrate further
security of supply to our customers, we have commenced construction of a second
VICTREX PEEK polymer powder manufacturing plant on our main UK site at Thornton
Cleveleys, Lancashire. With an estimated capital cost of £29m, the new plant
will have the capacity to support an additional 1,450 tonnes per annum of
VICTREX PEEK sales. Construction is expected to be completed in late 2007.
To utilise this additional polymer capacity fully we will also need to uprate
our BDF supply chain. We are currently carrying out a review of the supply chain
before proceeding to detailed design and costing.
The investments outlined above will enable us to increase capacity and further
improve product quality and customer service while giving us even greater
control of costs.
OUTLOOK
Sales volume has shown some strengthening since the year end. If this level of
demand is sustained, first half volume will be higher than the second half of
last year.
Despite weakening in our effective exchange rates, we still expect further
enhancement in our gross margin for the year to 30 September 2006, principally
due to the benefits arising from the recent acquisition of the BDF operations.
Peter Warry
Chairman
5 December 2005
CONSOLIDATED PROFIT AND LOSS ACCOUNT
2005 2004
For the year ended 30 September Note £000 £000
--------------------------- ------- ------- -------
Turnover: Group and share of Japanese joint venture 108,741 93,497
Less: share of Japanese joint venture (7,126) (6,921)
--------------------------- ------- ------- -------
Turnover 2 101,615 86,576
Cost of sales (43,628) (38,915)
--------------------------- ------- ------- -------
Gross profit 57,987 47,661
Sales, marketing and administrative expenses (23,733) (19,905)
--------------------------- ------- ------- -------
Group operating profit 34,254 27,756
Share of operating profit in Japanese joint venture 549 570
--------------------------- ------- ------- -------
Total operating profit 34,803 28,326
Interest receivable 419 271
Interest payable and other similar charges (143) (138)
--------------------------- ------- ------- -------
Profit on ordinary activities before taxation 35,079 28,459
Taxation on profit on ordinary activities (11,401) (9,249)
--------------------------- ------- ------- -------
Profit on ordinary activities after taxation 23,678 19,210
Equity dividends paid and proposed 8 (9,682) (6,853)
--------------------------- ------- ------- -------
Retained profit for the financial year 13,996 12,357
--------------------------- ------- ------- -------
The Company 2,856 6,005
Group undertakings and joint venture 11,140 6,352
--------------------------- ------- ------- -------
13,996 12,357
--------------------------- ------- ------- -------
Earnings per ordinary share Basic 3 29.3p 23.9p
Diluted 3 29.0p 23.7p
--------------------------- ------- ------- -------
The Group's turnover and operating profit arise from continuing operations in
both the current and preceding year.
There were no material differences between reported profits and historical cost
profits on ordinary activities before taxation in either of the above financial
years.
CONSOLIDATED BALANCE SHEET
2005 2004
As at 30 September £000 £000
------------------ ----------------- -------- ------
Fixed assets
Intangible assets 9,155 6,677
Tangible assets 63,812 49,347
Investment in Japanese joint
venture : share of gross assets 2,291 2,089
share of gross liabilities (2,266) (1,800)
---------------- ----------------- -------- -------
72,992 56,313
---------------- ----------------- -------- -------
Current assets
Stocks 19,936 18,833
Debtors 13,049 10,578
Cash at bank and in hand 15,821 17,004
-------------- -------------------- -------- -------
48,806 46,415
Creditors: amounts falling
due within one year (24,854) (22,704)
-------------- -------------------- -------- -------
Net current assets 23,952 23,711
-------------------------------- -------- -------
Total assets less current
liabilities 96,944 80,024
Provisions for liabilities
and charges (6,770) (6,070)
-------------- -------------------- -------- -------
Net assets 90,174 73,954
-------------- -------------------- -------- -------
Capital and reserves
Called up share capital 812 805
Share premium account 15,243 13,383
Profit and loss account 74,119 59,766
-------------------------------- -------- -------
Equity shareholders' funds 90,174 73,954
-------------------------------- -------- -------
These financial statements were approved by the Board of Directors on 5 December
2005 and were signed on its behalf by:
D R Hummel Chief Executive
M W Peacock Finance Director
CONSOLIDATED CASH FLOW STATEMENT
2005 2004
For the year ended 30 September Note £000 £000
---------------------------------- ----- ------- -------
Net cash inflow from operating activities 4 37,158 32,336
---------------------------------- ----- ------- -------
Return on investments and servicing of finance
Interest received 419 273
Interest paid (49) (36)
---------------------------------- ----- ------- -------
Net cash inflow from returns on investment and
servicing of finance 370 237
---------------------------------- ----- ------- -------
Taxation - Taxation paid (9,734) (6,070)
---------------------------------- ----- ------- -------
Net cash outflow from capital expenditure - Purchase
of (6,017) (9,468)
tangible fixed assets ----- ------- -------
----------------------------------
Acquisitions
Purchase of business (including opening inventory) 5 (16,300) -
Associated acquisition costs including stamp duty 5 (1,447) -
---------------------------------- ----- ------- -------
Net cash outflow from acquisition (17,747) -
---------------------------------- ----- ------- -------
Equity dividends paid (6,996) (6,112)
---------------------------------- ----- ------- -------
Net cash (outflow)/inflow before financing (2,966) 10,923
---------------------------------- ----- ------- -------
Financing
Issue of ordinary shares exercised under option 7 3
Premium on issue of ordinary shares exercised under
option 1,860 640
Purchase of own shares held (84) (602)
---------------------------------- ----- ------- -------
Net cash inflow from financing 1,783 41
---------------------------------- ----- ------- -------
(Decrease)/increase in cash in the year 6 (1,183) 10,964
---------------------------------- ----- ------- -------
CONSOLIDATED STATEMENT OF TOTAL RECOGNISED GAINS AND LOSSES
2005 2004
For the year ended 30 September £000 £000
--------------------------------- ------- -------
Profit for the financial year 23,678 19,210
Exchange loss on consolidation (114) (24)
--------------------------------- ------- -------
Total recognised gains and losses relating to the financial
year 23,564 19,186
--------------------------------- ------- -------
RECONCILIATION OF MOVEMENTS IN SHAREHOLDERS' FUNDS
2005 2004
For the year ended 30 September £000 £000
--------------------------------- ------- -------
Profit for the financial year 23,678 19,210
Equity dividends paid and proposed (9,682) (6,853)
--------------------------------- ------- -------
Retained profit for the financial year 13,996 12,357
Exchange loss on consolidation (114) (24)
Issue of ordinary shares exercised under option 7 3
Premium on issue of ordinary shares exercised under option 1,860 640
Purchase of own shares held (84) (602)
LTIP charge 555 443
--------------------------------- ------- -------
Net movement in shareholders' funds 16,220 12,817
Opening shareholders' funds 73,954 61,137
--------------------------------- ------- -------
Closing shareholders' funds 90,174 73,954
--------------------------------- ------- -------
NOTES TO THE FINANCIAL STATEMENTS
1 Basis of preparation
The financial statements have been prepared on the basis of the accounting
policies set out in the Group's last Annual Report and Accounts.
2 Analysis of turnover
An analysis of turnover by origin and customer location is as follows:
2005 2004
£000 £000
---------------------- --------- ----------
Europe 52,671 45,469
United States of America 32,444 28,799
Asia-Pacific 16,500 12,308
---------------------- --------- ----------
101,615 86,576
---------------------- --------- ----------
3 Earnings per share
2005 2004
---------------------- --------- ----------
Basic 29.3p 23.9p
Diluted 29.0p 23.7p
---------------------- --------- ----------
Earnings per ordinary share is based on the Group's profit on ordinary
activities after taxation of £23,678,000 (2004: £19,210,000).
The weighted average number of shares used in the calculation is: Basic
80,821,490 (2004: 80,394,636);
Diluted 81,692,949 (2004: 80,945,671).
4 Reconciliation of operating profit to net cash inflow from operating
activities
2005 2004
£000 £000
------------------------ -------- ---------
Operating profit 34,803 28,326
Depreciation and amortisation charge 5,508 4,860
------------------------ -------- ---------
Earnings before interest, taxation, depreciation and
amortisation 40,311 33,186
Increase in stocks (203) (2,418)
Increase in debtors (2,483) (1,221)
(Decrease)/increase in creditors (838) 3,130
LTIP charge 555 443
Japanese joint venture profit in stock elimination 479 (190)
Share of operating profit in Japanese joint venture (549) (570)
Effect of foreign exchange rate changes (114) (24)
------------------------ -------- ---------
Net cash inflow from operating activities 37,158 32,336
------------------------ -------- ---------
5 Purchase of business
On 1 April 2005 the BDF manufacturing operations were acquired from Degussa AG.
Net assets acquired £000
------------------------ ---------
Tangible fixed assets 12,900
Goodwill 2,500
Stock 900
------------------------ ---------
16,300
Associated acquisition costs including stamp duty 1,447
------------------------ ---------
Total cash consideration 17,747
------------------------ ---------
The resulting goodwill was capitalised and is being amortised to the profit and
loss account over its estimated useful economic life of 10 years.
This acquisition was funded from existing cash resources and borrowing
facilities. No fair value adjustments were made in relation to the acquired
assets.
Profit before tax attributable to these assets for the year ended 31 December
2004 amounted to £4.9m.
6 Reconciliation of net cash flow to movement in net cash
---------------------- ---------- ---------
2005 2004
£000 £000
---------------------- ---------- ---------
(Decrease)/increase in cash in year (1,183) 10,964
Cash outflow from decrease in debt - -
---------------------- ---------- ---------
Movement in net cash in year (1,183) 10,964
Net cash at beginning of year 17,004 6,040
---------------------- ---------- ---------
Net cash at end of year 15,821 17,004
---------------------- ---------- ---------
7 Exchange rates
The Sterling exchange rates used in the accounts under the Group's accounting
policies are:
Average Closing
exchange rate exchange rate
2005 2004 2005 2004
--------------- -------- -------- -------- --------
US Dollar 1.76 1.61 1.81 1.70
Euro 1.44 1.45 1.41 1.41
Yen 186 186 189 176
--------------- -------- -------- -------- --------
8 Dividend and Annual General Meeting
The proposed final dividend will be paid on 1 March 2006, to all shareholders on
the register on 3 February 2006. The Annual General Meeting of the Company will
be held on 7 February 2006, at The Great Eastern Hotel, Liverpool Street,
London, EC2M 7QN.
9 Financial Statements
The above financial information does not comprise full financial statements
within the meaning of the Companies Act 1985. The results for the years ended 30
September 2005 and 2004 have been extracted from the full accounts for those
periods. The auditors have given an unqualified report on the accounts for both
years. The accounts for the year ended 30 September 2004 have been delivered to
the Registrar of Companies. The accounts for the year ended 30 September 2005
are to be posted to shareholders on 16 December 2005 and will be available from
the Company's registered office at Victrex Technology Centre, Hillhouse
International, Thornton Cleveleys, Lancashire, FY5 4QD.
This information is provided by RNS
The company news service from the London Stock Exchange